,proposal_id,program,score,DOI,ISSN,journal_name,publisher,coci_citations,references,cr_subject,authors_count,title,created,deposited,indexed,published-online,issued,pmid,id,year,journal,discipline,wos_citations,citation_score,posts_count,research_highlight,twitter_accounts,patents,news_outlets,blogs,fb_pages,stackoverflow,videos,peer_reviews,weibo,gplus,reddit_threads,policies,syllabi,linkedin,wikipedia,n_trials
5584,PC081686,PCRP,0.8726621614864865,10.1056/nejmoa1207506,"['0028-4793', '1533-4406']",New England Journal of Medicine,Massachusetts Medical Society,2201.0,29.0,,20.0,Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy,2012.0,2017.0,2020.0,,2012.0,22894553,49230232.0,2012.0,NEW ENGLAND JOURNAL OF MEDICINE,Clinical Medicine,1762.0,88.12799999999999,186.0,1.0,110.0,28.0,3.0,4.0,12.0,,,,,,,2.0,,1.0,1.0,11.0
4721,PC073470,PCRP,0.8661056424876237,10.1016/j.ccr.2010.05.026,['1535-6108'],Cancer Cell,Elsevier BV,1887.0,59.0,,26.0,Integrative Genomic Profiling of Human Prostate Cancer,2010.0,2019.0,2020.0,,2010.0,20579941,44742524.0,2010.0,CANCER CELL,Clinical Medicine,1693.0,48.562,37.0,,4.0,33.0,,,,,,,,,,,,,,
4069,PC051382,PCRP,0.8873198839285714,10.1126/science.1168175,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),1128.0,17.0,['Multidisciplinary'],19.0,Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer,2009.0,2020.0,2020.0,2009.0,2009.0,19359544,32005806.0,2009.0,SCIENCE,Biomedical Research,1047.0,17.511,76.0,1.0,,61.0,1.0,2.0,,,,,,,,1.0,,,10.0,2.0
718,TS060023,TSCRP,0.9620916826849024,10.1016/j.cell.2010.02.024,['0092-8674'],Cell,Elsevier BV,1242.0,40.0,,6.0,Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids,2010.0,2019.0,2020.0,,2010.0,20381137,44319820.0,2010.0,CELL,Biomedical Research,1036.0,30.319000000000003,15.0,3.0,2.0,5.0,,2.0,,,,,,,,,,,1.0,
5798,PC094290,PCRP,0.8604608421428572,10.1038/nature11125,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,1183.0,23.0,,27.0,The mutational landscape of lethal castration-resistant prostate cancer,2012.0,2019.0,2020.0,2012.0,2012.0,22722839,49064481.0,2012.0,NATURE,Biomedical Research,976.0,31.250999999999998,39.0,1.0,23.0,8.0,,1.0,2.0,,,,,,,,,,2.0,
382,NF093145,NFRP,0.806728207840909,10.1016/j.devcel.2010.09.011,['1534-5807'],Developmental Cell,Elsevier BV,1195.0,181.0,,1.0,The Hippo Signaling Pathway in Development and Cancer,2010.0,2018.0,2020.0,,2010.0,20951342,45171047.0,2010.0,DEVELOPMENTAL CELL,Biomedical Research,965.0,24.676,11.0,,1.0,4.0,,2.0,,,,,,,,,,,3.0,
724,TS060023,TSCRP,0.9439840777777779,10.1074/jbc.m900301200,"['0021-9258', '1083-351X']",Journal of Biological Chemistry,American Society for Biochemistry & Molecular Biology (ASBMB),1056.0,43.0,"['Cell Biology', 'Biochemistry', 'Molecular Biology']",10.0,An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1,2009.0,2019.0,2020.0,2009.0,2009.0,19150980,31431935.0,2009.0,JOURNAL OF BIOLOGICAL CHEMISTRY,Biomedical Research,947.0,23.651999999999997,24.0,,,23.0,,1.0,,,,,,,,,,,,
5831,PC094371,PCRP,0.8616781708108107,10.1038/nm.2284,"['1078-8956', '1546-170X']",Nature Medicine,Springer Science and Business Media LLC,826.0,39.0,,15.0,The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44,2011.0,2019.0,2020.0,2011.0,2011.0,21240262,46204374.0,2011.0,NATURE MEDICINE,Biomedical Research,756.0,24.295,18.0,2.0,,8.0,,3.0,1.0,,,,,,,,,,1.0,
5213,PC080617,PCRP,0.7628667318181819,10.1073/pnas.1012539107,"['0027-8424', '1091-6490']",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,1028.0,30.0,,23.0,Isolation of circulating tumor cells using a microvortex-generating herringbone-chip,2010.0,2017.0,2020.0,2010.0,2010.0,20930119,45190711.0,2010.0,PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,Biomedical Research,753.0,14.424000000000001,49.0,,3.0,44.0,,2.0,,,,,,,,,,,,2.0
7286,PC140318,PCRP,0.8765068891221375,10.1038/nrc.2016.108,"['1474-175X', '1474-1768']",Nature Reviews Cancer,Springer Science and Business Media LLC,1556.0,297.0,"['Cancer Research', 'Oncology']",4.0,"Cancer nanomedicine: progress, challenges and opportunities",2016.0,2020.0,2020.0,2016.0,2016.0,27834398,59628231.0,2017.0,NATURE REVIEWS CANCER,Clinical Medicine,682.0,122.31299999999999,177.0,,153.0,1.0,1.0,,12.0,,,,,,,,,,,
6954,PC121552,PCRP,0.8967735257575757,10.1038/ng.3192,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,1084.0,61.0,,19.0,The landscape of long noncoding RNAs in the human transcriptome,2015.0,2019.0,2020.0,2015.0,2015.0,25599403,54292881.0,2015.0,NATURE GENETICS,Biomedical Research,655.0,51.556999999999995,150.0,,115.0,,7.0,2.0,2.0,2.0,,,,3.0,,,,,2.0,
5649,PC093372P1,PCRP,0.7893863507692308,10.1038/ng.2279,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,769.0,54.0,,46.0,"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer",2012.0,2019.0,2020.0,2012.0,2012.0,22610119,48577085.0,2012.0,NATURE GENETICS,Biomedical Research,648.0,23.671,28.0,,12.0,8.0,4.0,1.0,,,,,,,,,,,2.0,
4954,PC074012,PCRP,0.9655163490420692,10.1016/j.ymeth.2010.01.032,['1046-2023'],Methods,Elsevier BV,723.0,12.0,,4.0,Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR),2010.0,2018.0,2020.0,,2010.0,20146939,44258204.0,2010.0,METHODS-A COMPANION TO METHODS IN ENZYMOLOGY,Biomedical Research,622.0,18.203,9.0,,1.0,7.0,,,1.0,,,,,,,,,,,1.0
5144,PC080421,PCRP,0.6954397236781611,10.1016/s0140-6736(10)60172-9,['0140-6736'],The Lancet,Elsevier BV,645.0,30.0,,19.0,Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study,2010.0,2019.0,2020.0,,2010.0,,44383078.0,2010.0,LANCET,Clinical Medicine,593.0,23.438000000000002,11.0,2.0,,6.0,,1.0,,,,,,,,,,,2.0,
6284,PC101832,PCRP,0.8731122005487805,10.1038/nature10912,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,677.0,41.0,,19.0,The translational landscape of mTOR signalling steers cancer initiation and metastasis,2012.0,2019.0,2020.0,2012.0,2012.0,22367541,48446760.0,2012.0,NATURE,Biomedical Research,555.0,17.771,36.0,1.0,17.0,11.0,,,1.0,,,1.0,,2.0,,,,,,
716,TS060023,TSCRP,0.8392311754057428,10.1126/science.1199498,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),646.0,31.0,['Multidisciplinary'],12.0,The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling,2011.0,2020.0,2020.0,2011.0,2011.0,21659604,46772352.0,2011.0,SCIENCE,Biomedical Research,552.0,13.395,16.0,1.0,8.0,3.0,,1.0,,,,,,,,,,,1.0,
5795,PC094290,PCRP,0.9494096505032644,10.1038/nbt.1914,"['1087-0156', '1546-1696']",Nature Biotechnology,Springer Science and Business Media LLC,601.0,48.0,"['Biotechnology', 'Molecular Medicine', 'Applied Microbiology and Biotechnology', 'Bioengineering', 'Biomedical Engineering']",20.0,"Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression",2011.0,2020.0,2020.0,2011.0,2011.0,21804560,47048445.0,2011.0,NATURE BIOTECHNOLOGY,Biomedical Research,513.0,12.449000000000002,30.0,,7.0,21.0,,,1.0,,,,,,,,,,,
5933,PC094516,PCRP,0.8635467091592921,10.1016/j.cell.2013.03.021,['0092-8674'],Cell,Elsevier BV,632.0,61.0,"['General Biochemistry, Genetics and Molecular Biology']",43.0,Punctuated Evolution of Prostate Cancer Genomes,2013.0,2019.0,2020.0,,2013.0,23622249,50372641.0,2013.0,CELL,Biomedical Research,467.0,19.305999999999997,51.0,1.0,35.0,7.0,2.0,2.0,,,,,,,,,,,1.0,
4208,PC060508,PCRP,0.8924627424418604,10.1158/0008-5472.can-08-3795,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),472.0,,,14.0,A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth,2009.0,2016.0,2020.0,2009.0,2009.0,19244107,32421892.0,2009.0,CANCER RESEARCH,Clinical Medicine,449.0,11.325999999999999,37.0,,,35.0,,,,,,,,,,,,,1.0,
4822,PC073716,PCRP,0.8486591581912811,10.1101/gad.1965810,['0890-9369'],Genes & Development,Cold Spring Harbor Laboratory,494.0,,,2.0,Molecular genetics of prostate cancer: new prospects for old challenges,2010.0,2017.0,2020.0,2010.0,2010.0,20844012,44979440.0,2010.0,GENES & DEVELOPMENT,Biomedical Research,436.0,11.984000000000002,6.0,,1.0,5.0,,,,,,,,,,,,,,
4776,PC073615,PCRP,0.9537864759820944,10.1038/nature10006,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,515.0,40.0,,13.0,Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA,2011.0,2019.0,2020.0,2011.0,2011.0,21572438,46795169.0,2011.0,NATURE,Biomedical Research,422.0,10.241,12.0,1.0,5.0,3.0,,1.0,,,,1.0,,,,,,,1.0,
5245,PC080665,PCRP,0.9435511371428572,10.1016/j.ccr.2010.03.018,['1535-6108'],Cancer Cell,Elsevier BV,451.0,48.0,,24.0,"An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression",2010.0,2018.0,2020.0,,2010.0,20478527,44468947.0,2010.0,CANCER CELL,Clinical Medicine,414.0,11.875,20.0,,,16.0,,1.0,,,,,,,,,,,3.0,
4953,PC074012,PCRP,0.8572387134469697,10.1158/1940-6207.capr-11-0370,"['1940-6207', '1940-6215']",Cancer Prevention Research,American Association for Cancer Research (AACR),516.0,,,8.0,Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies,2011.0,2016.0,2020.0,2011.0,2011.0,22158052,48139317.0,2012.0,CANCER PREVENTION RESEARCH,Clinical Medicine,409.0,15.825999999999999,11.0,,3.0,8.0,,,,,,,,,,,,,,
6583,PC111410,PCRP,0.7445054278225807,10.1038/nrc3627,"['1474-175X', '1474-1768']",Nature Reviews Cancer,Springer Science and Business Media LLC,507.0,200.0,"['Cancer Research', 'Oncology']",2.0,VEGF targets the tumour cell,2013.0,2019.0,2020.0,2013.0,2013.0,24263190,51486239.0,2013.0,NATURE REVIEWS CANCER,Clinical Medicine,406.0,18.088,14.0,,7.0,6.0,,,1.0,,,,,,,,,,,
3525,PC050114,PCRP,0.7864053089383561,10.1146/annurev.pathol.4.110807.092222,"['1553-4006', '1553-4014']",Annual Review of Pathology: Mechanisms of Disease,Annual Reviews,478.0,210.0,['Pathology and Forensic Medicine'],2.0,MicroRNAs in Cancer,2008.0,2017.0,2020.0,,2009.0,18817506,32109494.0,2009.0,ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE,Clinical Medicine,391.0,17.45,6.0,,,4.0,,1.0,,,,,,1.0,,,,,,
5866,PC094421,PCRP,0.8625007766509435,10.1093/bioinformatics/bts356,"['1460-2059', '1367-4803']",Bioinformatics,Oxford University Press (OUP),721.0,7.0,,3.0,RSeQC: quality control of RNA-seq experiments,2012.0,2017.0,2020.0,2012.0,2012.0,22743226,48939861.0,2012.0,BIOINFORMATICS,Biology,379.0,14.25,13.0,,8.0,2.0,,,,,,,,,,,,,1.0,
3230,PC040429,PCRP,0.9307635344594596,10.1038/nature08361,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,416.0,50.0,,10.0,A luminal epithelial stem cell that is a cell of origin for prostate cancer,2009.0,2019.0,2020.0,2009.0,2009.0,19741607,32845447.0,2009.0,NATURE,Biomedical Research,374.0,6.255,8.0,1.0,1.0,2.0,1.0,1.0,,,,,,,,,,,,
5313,PC081044,PCRP,0.8274158714787891,10.1371/journal.pone.0006146,['1932-6203'],PLoS ONE,Public Library of Science (PLoS),409.0,,,12.0,Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery,2009.0,2018.0,2020.0,2009.0,2009.0,19582160,43726202.0,2009.0,PLOS ONE,Biomedical Research,372.0,6.222,5.0,,,4.0,,,,,,,,,,,,,1.0,
770,TS080031,TSCRP,0.8306800188034188,10.1038/nrm3522,"['1471-0072', '1471-0080']",Nature Reviews Molecular Cell Biology,Springer Science and Business Media LLC,443.0,53.0,"['Cell Biology', 'Molecular Biology']",3.0,Amino acid signalling upstream of mTOR,2013.0,2019.0,2020.0,2013.0,2013.0,23361334,50206832.0,2013.0,NATURE REVIEWS MOLECULAR CELL BIOLOGY,Biomedical Research,354.0,14.634,25.0,,20.0,1.0,,,2.0,,,,,,,,,,1.0,
4765,PC073604,PCRP,0.8111595017857143,10.1021/ja909551b,"['0002-7863', '1520-5126']",Journal of the American Chemical Society,American Chemical Society (ACS),400.0,26.0,,4.0,Sensitive and Selective Amplified Fluorescence DNA Detection Based on Exonuclease III-Aided Target Recycling,2010.0,2019.0,2020.0,,2010.0,20092337,44113117.0,2010.0,JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,Chemistry,351.0,9.226,7.0,,,7.0,,,,,,,,,,,,,,
4704,PC073392,PCRP,0.7629426947058824,10.1126/science.1168988,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),383.0,28.0,['Multidisciplinary'],4.0,CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses,2009.0,2020.0,2020.0,2009.0,2009.0,19264983,31916563.0,2009.0,SCIENCE,Biomedical Research,349.0,5.837000000000001,9.0,2.0,,3.0,,,,,,,,,,,,,1.0,1.0
4170,PC060385,PCRP,0.8397235090027589,10.1126/science.1179052,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),383.0,20.0,['Multidisciplinary'],13.0,"Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome",2009.0,2020.0,2020.0,2009.0,2009.0,,32412147.0,2009.0,SCIENCE,Biomedical Research,340.0,5.687,299.0,1.0,73.0,13.0,83.0,50.0,7.0,,2.0,,,,,,,,5.0,
4777,PC073615,PCRP,0.4353168850632912,10.1016/j.cell.2009.11.030,['0092-8674'],Cell,Elsevier BV,369.0,55.0,"['General Biochemistry, Genetics and Molecular Biology']",11.0,Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer,2009.0,2020.0,2020.0,,2009.0,19962179,32697804.0,2009.0,CELL,Biomedical Research,339.0,8.467,9.0,1.0,,5.0,,,,,,1.0,,,,,,,,
5237,PC080665,PCRP,0.9666748108167084,10.1101/gad.173435.111,['0890-9369'],Genes & Development,Cold Spring Harbor Laboratory,406.0,,,6.0,Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis,2012.0,2017.0,2020.0,2012.0,2012.0,22215811,47964182.0,2012.0,GENES & DEVELOPMENT,Biomedical Research,329.0,12.017999999999999,1.0,,,1.0,,,,,,,,,,,,,,
6183,PC100950,PCRP,0.9612089784898358,10.1158/1078-0432.ccr-11-0728,"['1078-0432', '1557-3265']",Clinical Cancer Research,American Association for Cancer Research (AACR),319.0,,,8.0,Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants,2011.0,2017.0,2020.0,2011.0,2011.0,21807635,47211454.0,2011.0,CLINICAL CANCER RESEARCH,Clinical Medicine,329.0,10.74,18.0,1.0,,17.0,,,,,,,,,,,,,,
6407,PC102106,PCRP,0.9502673353579932,10.1016/j.cell.2013.11.012,['0092-8674'],Cell,Elsevier BV,384.0,33.0,"['General Biochemistry, Genetics and Molecular Biology']",12.0,Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade,2013.0,2019.0,2020.0,,2013.0,24315100,51571357.0,2013.0,CELL,Biomedical Research,328.0,13.56,46.0,1.0,11.0,12.0,2.0,,,,,,,,,,,,1.0,1.0
5784,PC094266,PCRP,0.866955235388418,10.1038/nbt.2038,"['1087-0156', '1546-1696']",Nature Biotechnology,Springer Science and Business Media LLC,449.0,50.0,,22.0,Single-cell dissection of transcriptional heterogeneity in human colon tumors,2011.0,2019.0,2020.0,2011.0,2011.0,22081019,47685947.0,2011.0,NATURE BIOTECHNOLOGY,Biomedical Research,327.0,7.935,45.0,1.0,13.0,24.0,,,1.0,,,,,1.0,,,,,1.0,
4732,PC073533,PCRP,0.7713852189655173,10.1038/nm.1944,"['1078-8956', '1546-170X']",Nature Medicine,Springer Science and Business Media LLC,399.0,35.0,,18.0,Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer,2009.0,2019.0,2020.0,2009.0,2009.0,19363497,31753282.0,2009.0,NATURE MEDICINE,Biomedical Research,325.0,8.117,7.0,1.0,,4.0,,,,,,,,,,,,,1.0,
6179,PC100950,PCRP,0.8070275431457431,10.1126/science.1227604,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),392.0,44.0,['Multidisciplinary'],22.0,EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent,2012.0,2020.0,2020.0,2012.0,2012.0,23239736,49600428.0,2012.0,SCIENCE,Biomedical Research,321.0,10.277999999999999,16.0,1.0,11.0,1.0,,1.0,1.0,,,,,,,,,,,
6903,PC121341,PCRP,0.8640497442829458,10.1016/j.cell.2014.08.016,['0092-8674'],Cell,Elsevier BV,512.0,47.0,,39.0,Organoid Cultures Derived from Patients with Advanced Prostate Cancer,2014.0,2018.0,2020.0,,2014.0,25201530,53365086.0,2014.0,CELL,Biomedical Research,321.0,16.325,36.0,1.0,21.0,3.0,5.0,1.0,3.0,,,,1.0,,,,,,,
381,NF093145,NFRP,0.8388688196078431,10.1016/j.devcel.2010.06.015,['1534-5807'],Developmental Cell,Elsevier BV,396.0,61.0,,10.0,The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals,2010.0,2018.0,2020.0,,2010.0,20643348,44798106.0,2010.0,DEVELOPMENTAL CELL,Biomedical Research,319.0,8.157,2.0,,,1.0,,,,,,,,,,,,,1.0,
6009,PC100374,PCRP,0.9168536021428572,10.1038/nrm3274,"['1471-0072', '1471-0080']",Nature Reviews Molecular Cell Biology,Springer Science and Business Media LLC,459.0,116.0,,2.0,Understanding the language of Lys36 methylation at histone H3,2012.0,2019.0,2020.0,2012.0,2012.0,22266761,48028214.0,2012.0,NATURE REVIEWS MOLECULAR CELL BIOLOGY,Biomedical Research,318.0,11.311,5.0,,4.0,,,,,,,,,,,,,,1.0,
5135,PC080377,PCRP,0.8091211357543859,10.1038/nature09732,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,356.0,30.0,,20.0,SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction,2011.0,2019.0,2020.0,2011.0,2011.0,21368833,46315511.0,2011.0,NATURE,Biomedical Research,317.0,7.693,8.0,1.0,,2.0,,1.0,1.0,,,,,,,,,,,
5742,PC094021,PCRP,0.9368962371135235,10.1158/1541-7786.mcr-10-0490,"['1541-7786', '1557-3125']",Molecular Cancer Research,American Association for Cancer Research (AACR),386.0,,,10.0,Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers,2011.0,2016.0,2020.0,2011.0,2011.0,21665936,47072413.0,2011.0,MOLECULAR CANCER RESEARCH,Clinical Medicine,315.0,10.283,10.0,,1.0,8.0,,,1.0,,,,,,,,,,,
4925,PC073952,PCRP,0.9181016780487804,10.1172/jci43414,['0021-9738'],Journal of Clinical Investigation,American Society for Clinical Investigation,406.0,41.0,,17.0,Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow,2011.0,2017.0,2020.0,,2011.0,21436587,46476043.0,2011.0,JOURNAL OF CLINICAL INVESTIGATION,Clinical Medicine,312.0,13.868,91.0,2.0,85.0,1.0,,1.0,,,,,,,,,,,,
6349,PC101964,PCRP,0.7780813319909371,10.1038/nbt.2459,"['1087-0156', '1546-1696']",Nature Biotechnology,Springer Science and Business Media LLC,386.0,34.0,,5.0,Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells,2012.0,2019.0,2020.0,2012.0,2012.0,23242161,49922035.0,2013.0,NATURE BIOTECHNOLOGY,Biomedical Research,309.0,12.061,55.0,,18.0,29.0,1.0,1.0,3.0,,,,,1.0,,,,,,
882,TS100062,TSCRP,0.975084762544168,10.1038/nature10658,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,364.0,44.0,,3.0,Mutations causing syndromic autism define an axis of synaptic pathophysiology,2011.0,2019.0,2020.0,2011.0,2011.0,22113615,47572660.0,2011.0,NATURE,Biomedical Research,309.0,7.499,60.0,1.0,18.0,26.0,,5.0,,,,,,1.0,,,,,,
5242,PC080665,PCRP,0.9142466714285716,10.1101/gad.1903310,['0890-9369'],Genes & Development,Cold Spring Harbor Laboratory,377.0,,,12.0,The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation,2010.0,2017.0,2020.0,2010.0,2010.0,20516196,44522407.0,2010.0,GENES & DEVELOPMENT,Biomedical Research,301.0,8.273,5.0,,,5.0,,,,,,,,,,,,,,
5987,PC100171,PCRP,0.9261657496807152,10.1038/ng.2771,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,356.0,63.0,['Genetics'],29.0,The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex,2013.0,2019.0,2020.0,2013.0,2013.0,24076601,51351828.0,2013.0,NATURE GENETICS,Biomedical Research,300.0,12.334000000000001,21.0,,16.0,2.0,,,,,,,,1.0,,,,,,
5972,PC094715,PCRP,0.7113152153012048,10.1126/scitranslmed.3005616,"['1946-6234', '1946-6242']",Science Translational Medicine,American Association for the Advancement of Science (AAAS),581.0,30.0,['General Medicine'],30.0,Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells,2013.0,2020.0,2020.0,2013.0,2013.0,23552373,50265417.0,2013.0,SCIENCE TRANSLATIONAL MEDICINE,Biomedical Research,297.0,12.277999999999999,60.0,,26.0,12.0,9.0,3.0,3.0,,,,1.0,,,,,,1.0,1.0
4559,PC061456,PCRP,0.924852320038168,10.1126/science.1189992,"['0036-8075', '1095-9203']",Science,American Association for the Advancement of Science (AAAS),337.0,31.0,['Multidisciplinary'],5.0,Identification of a Cell of Origin for Human Prostate Cancer,2010.0,2020.0,2020.0,2010.0,2010.0,20671189,44800709.0,2010.0,SCIENCE,Biomedical Research,295.0,5.651,7.0,3.0,,1.0,1.0,,,,,,,,,,,,1.0,
802,TS080074,TSCRP,0.5318806403977433,10.1002/dneu.20765,"['1932-8451', '1932-846X']",Developmental Neurobiology,Wiley,79.0,134.0,,2.0,"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease",2010.0,2019.0,2020.0,,2010.0,20186705,44303754.0,2010.0,DEVELOPMENTAL NEUROBIOLOGY,Clinical Medicine,295.0,9.61,2.0,,,,,,,,,,,1.0,,,,,,
3473,PC041206,PCRP,0.8217925328121687,10.1158/0008-5472.can-08-4709,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),330.0,,,10.0,The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies,2009.0,2016.0,2020.0,2009.0,2009.0,19276342,31580810.0,2009.0,CANCER RESEARCH,Clinical Medicine,292.0,7.3660000000000005,7.0,,,7.0,,,,,,,,,,,,,,1.0
5406,PC081559,PCRP,0.9376422958633092,10.1038/ng.556,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,323.0,21.0,,13.0,Subtle variations in Pten dose determine cancer susceptibility,2010.0,2019.0,2020.0,2010.0,2010.0,20400965,44378648.0,2010.0,NATURE GENETICS,Biomedical Research,290.0,7.971,2.0,1.0,1.0,,,,,,,,,,,,,,,
4144,PC060283,PCRP,0.8916239789102564,10.1038/ng.545,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,303.0,32.0,,15.0,Nucleosome dynamics define transcriptional enhancers,2010.0,2019.0,2020.0,2010.0,2010.0,20208536,44243104.0,2010.0,NATURE GENETICS,Biomedical Research,290.0,7.971,4.0,1.0,,2.0,,,,,,,,,,,,,,
967,TS130044,TSCRP,0.9805465913399132,10.1016/j.cell.2015.10.012,['0092-8674'],Cell,Elsevier BV,486.0,32.0,,9.0,5′ UTR m6A Promotes Cap-Independent Translation,2015.0,2018.0,2020.0,,2015.0,26593424,55762686.0,2015.0,CELL,Biomedical Research,286.0,18.459,35.0,1.0,31.0,,2.0,1.0,,,,,,,,,,,,
5841,PC094384,PCRP,0.8836033910434664,10.1158/0008-5472.can-12-3630,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),310.0,,,6.0,Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines,2012.0,2016.0,2020.0,2012.0,2012.0,23117885,49936088.0,2013.0,CANCER RESEARCH,Clinical Medicine,281.0,12.519,23.0,,2.0,21.0,,,,,,,,,,,,,,
5484,PC081610,PCRP,0.919526389572072,10.1200/jco.2009.25.9259,"['0732-183X', '1527-7755']",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),294.0,31.0,"['Cancer Research', 'Oncology']",17.0,Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer,2010.0,2019.0,2020.0,,2010.0,20159814,44198455.0,2010.0,JOURNAL OF CLINICAL ONCOLOGY,Clinical Medicine,278.0,7.974,5.0,1.0,,4.0,,,,,,,,,,,,,,2.0
6029,PC100473,PCRP,0.8171846163461539,10.1039/c2nr31040f,"['2040-3364', '2040-3372']",Nanoscale,Royal Society of Chemistry (RSC),336.0,106.0,,4.0,Graphene: a versatile nanoplatform for biomedical applications,2012.0,2017.0,2020.0,,2012.0,22653227,48658784.0,2012.0,NANOSCALE,Engineering and Technology,277.0,11.838,4.0,,,4.0,,,,,,,,,,,,,,
4908,PC073887,PCRP,0.9734328473539852,10.1016/j.drudis.2011.09.009,['1359-6446'],Drug Discovery Today,Elsevier BV,332.0,104.0,,3.0,Curcumin nanoformulations: a future nanomedicine for cancer,2011.0,2019.0,2020.0,,2012.0,21959306,47997271.0,2012.0,DRUG DISCOVERY TODAY,Clinical Medicine,269.0,14.464,71.0,,20.0,3.0,,1.0,3.0,,1.0,,,,,,,,,
6287,PC101832,PCRP,0.9539552423913044,10.1016/j.ccr.2010.01.021,['1535-6108'],Cancer Cell,Elsevier BV,262.0,49.0,,9.0,Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E,2010.0,2018.0,2020.0,,2010.0,20227039,44195899.0,2010.0,CANCER CELL,Clinical Medicine,268.0,7.687,5.0,1.0,,4.0,,,,,,,,,,,,,,
4521,PC061397,PCRP,0.8303379792230906,10.1002/humu.20822,"['1059-7794', '1098-1004']",Human Mutation,Wiley,324.0,40.0,"['Genetics(clinical)', 'Genetics']",12.0,Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America,2008.0,2019.0,2020.0,,2009.0,18683858,31549941.0,2009.0,HUMAN MUTATION,Biomedical Research,267.0,6.629,8.0,,2.0,3.0,,,,,,,,1.0,,,,,2.0,
2599,PC030481,PCRP,0.6366834009330083,10.1038/nature08782,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,299.0,39.0,,5.0,B-cell-derived lymphotoxin promotes castration-resistant prostate cancer,2010.0,2019.0,2020.0,,2010.0,20220849,44145841.0,2010.0,NATURE,Biomedical Research,267.0,5.115,6.0,1.0,,5.0,,,,,,,,,,,,,,
5681,PC093509,PCRP,0.9431820229042764,10.1158/0008-5472.can-11-3892,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),277.0,,,12.0,Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer,2012.0,2016.0,2020.0,2012.0,2012.0,22710436,49077944.0,2012.0,CANCER RESEARCH,Clinical Medicine,264.0,10.215,14.0,,1.0,13.0,,,,,,,,,,,,,,
918,TS110056,TSCRP,0.9635770389471894,10.1016/j.neuron.2014.07.040,['0896-6273'],Neuron,Elsevier BV,421.0,63.0,,17.0,Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits,2014.0,2019.0,2020.0,,2014.0,25155956,53157228.0,2014.0,NEURON,Clinical Medicine,264.0,16.405,280.0,1.0,189.0,6.0,34.0,13.0,10.0,,,,9.0,4.0,1.0,,,,,2.0
5485,PC081610,PCRP,0.9010402071070148,10.1200/jco.2009.24.6819,"['0732-183X', '1527-7755']",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),269.0,26.0,"['Cancer Research', 'Oncology']",20.0,"Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate",2010.0,2019.0,2020.0,,2010.0,20159823,44198454.0,2010.0,JOURNAL OF CLINICAL ONCOLOGY,Clinical Medicine,262.0,7.515,5.0,,,4.0,,,,,,,,,,1.0,,,,1.0
3354,PC040768,PCRP,0.6014733801423099,10.1016/j.ccr.2010.04.027,['1535-6108'],Cancer Cell,Elsevier BV,266.0,58.0,,14.0,Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor,2010.0,2018.0,2020.0,,2010.0,20541699,44610851.0,2010.0,CANCER CELL,Clinical Medicine,259.0,7.428999999999999,25.0,2.0,1.0,20.0,,,,,,,,,,,,,1.0,
3806,PC051037,PCRP,0.912120275595238,10.1093/aje/kwp006,"['0002-9262', '1476-6256']",American Journal of Epidemiology,Oxford University Press (OUP),331.0,36.0,,5.0,Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California,2009.0,2019.0,2020.0,2009.0,2009.0,19270050,31595191.0,2009.0,AMERICAN JOURNAL OF EPIDEMIOLOGY,Clinical Medicine,257.0,9.497,15.0,,2.0,,4.0,1.0,1.0,,,,,,,2.0,,,,
4015,PC051369,PCRP,0.7218416602884615,10.1093/jnci/djp404,"['0027-8874', '1460-2105']",JNCI Journal of the National Cancer Institute,Oxford University Press (OUP),304.0,34.0,,4.0,Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer,2009.0,2019.0,2020.0,2009.0,2009.0,19996060,43944869.0,2010.0,JOURNAL OF THE NATIONAL CANCER INSTITUTE,Clinical Medicine,253.0,7.257000000000001,1.0,,,,,,,,,,,,,1.0,,,,1.0
6413,PC102171,PCRP,0.8751624441134752,10.1158/2159-8290.cd-13-0050,"['2159-8274', '2159-8290']",Cancer Discovery,American Association for Cancer Research (AACR),314.0,,['Oncology'],25.0,Identification of Targetable FGFR Gene Fusions in Diverse Cancers,2013.0,2017.0,2020.0,2013.0,2013.0,23558953,50754745.0,2013.0,CANCER DISCOVERY,Clinical Medicine,253.0,11.272,24.0,,5.0,13.0,6.0,,,,,,,,,,,,,1.0
5497,PC081610,PCRP,0.7943670675084297,10.1200/jco.2009.24.1281,"['0732-183X', '1527-7755']",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),255.0,18.0,"['Cancer Research', 'Oncology']",12.0,Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy,2010.0,2019.0,2020.0,,2010.0,20159824,44198453.0,2010.0,JOURNAL OF CLINICAL ONCOLOGY,Clinical Medicine,251.0,7.2,3.0,,,3.0,,,,,,,,,,,,,,2.0
4608,PC073073,PCRP,0.9312138921710524,10.1016/j.ccr.2011.05.006,['1535-6108'],Cancer Cell,Elsevier BV,268.0,67.0,,11.0,Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth,2011.0,2018.0,2020.0,,2011.0,21620777,46820403.0,2011.0,CANCER CELL,Clinical Medicine,249.0,8.129,13.0,1.0,,12.0,,,,,,,,,,,,,,1.0
5461,PC081610,PCRP,0.9394333991097036,10.1093/annonc/mdt107,['0923-7534'],Annals of Oncology,Elsevier BV,294.0,48.0,"['Oncology', 'Hematology']",11.0,"Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study",2013.0,2020.0,2020.0,,2013.0,23535954,50777995.0,2013.0,ANNALS OF ONCOLOGY,Clinical Medicine,247.0,11.005,9.0,,2.0,7.0,,,,,,,,,,,,,,2.0
363,NF093047,NFRP,0.9784828466172808,10.1016/j.cell.2014.03.060,['0092-8674'],Cell,Elsevier BV,366.0,49.0,"['General Biochemistry, Genetics and Molecular Biology']",10.0,Hippo Pathway Activity Influences Liver Cell Fate,2014.0,2018.0,2020.0,,2014.0,24906150,53093872.0,2014.0,CELL,Biomedical Research,246.0,12.511,30.0,1.0,11.0,1.0,4.0,4.0,4.0,,,,2.0,1.0,,,,,,
5359,PC081292,PCRP,0.8382327677852348,10.1038/nature08815,"['0028-0836', '1476-4687']",Nature,Springer Science and Business Media LLC,251.0,42.0,,13.0,Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence,2010.0,2019.0,2020.0,,2010.0,20237562,44178437.0,2010.0,NATURE,Biomedical Research,245.0,4.6930000000000005,14.0,1.0,2.0,9.0,,,,,,,,,,,,,1.0,
6286,PC101832,PCRP,0.7176788212041295,10.1016/j.cell.2011.03.028,['0092-8674'],Cell,Elsevier BV,301.0,77.0,,9.0,Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning,2011.0,2019.0,2020.0,,2011.0,21529712,46586575.0,2011.0,CELL,Biomedical Research,243.0,7.809,25.0,2.0,7.0,,1.0,4.0,,,,1.0,,,,,,,,
4830,PC073745,PCRP,0.9497134922228764,10.1158/0008-5472.can-09-1448,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),260.0,,,12.0,miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth,2009.0,2016.0,2020.0,2009.0,2009.0,19738047,32708429.0,2009.0,CANCER RESEARCH,Clinical Medicine,242.0,6.104,,,,,,,,,,,,,,,,,,
243,NF043050,NFRP,0.9495516453230508,10.1016/j.ccr.2008.12.006,['1535-6108'],Cancer Cell,Elsevier BV,362.0,44.0,,8.0,Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model,2009.0,2019.0,2020.0,,2009.0,19111880,31324812.0,2009.0,CANCER CELL,Clinical Medicine,240.0,6.053999999999999,2.0,1.0,,1.0,,,,,,,,,,,,,,
6410,PC102171,PCRP,0.9475554696153846,10.1038/ng.2509,"['1061-4036', '1546-1718']",Nature Genetics,Springer Science and Business Media LLC,364.0,24.0,,21.0,Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing,2013.0,2019.0,2020.0,2013.0,2013.0,23313952,49985217.0,2013.0,NATURE GENETICS,Biomedical Research,240.0,9.867,19.0,,12.0,3.0,2.0,,1.0,,,,,,,,,,,1.0
6702,PC111969,PCRP,0.8338148415516552,10.1001/jamaoncol.2015.1341,['2374-2437'],JAMA Oncology,American Medical Association (AMA),325.0,,,12.0,Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer,2015.0,2015.0,2020.0,,2015.0,26181238,57719383.0,2015.0,JAMA ONCOLOGY,Clinical Medicine,240.0,15.793,68.0,,39.0,3.0,7.0,1.0,3.0,,,,,1.0,,,,,,2.0
4900,PC073887,PCRP,0.9399267397668064,10.1016/j.jcis.2010.05.022,['0021-9797'],Journal of Colloid and Interface Science,Elsevier BV,311.0,57.0,,4.0,Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells,2010.0,2019.0,2020.0,,2010.0,20627257,45039061.0,2010.0,JOURNAL OF COLLOID AND INTERFACE SCIENCE,Chemistry,238.0,10.128,4.0,,,3.0,,,1.0,,,,,,,,,,,
5239,PC080665,PCRP,0.8001016213675214,10.1016/j.ccr.2011.04.010,['1535-6108'],Cancer Cell,Elsevier BV,252.0,55.0,,28.0,Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer,2011.0,2018.0,2020.0,,2011.0,21575865,46699041.0,2011.0,CANCER CELL,Clinical Medicine,236.0,7.704,9.0,1.0,,8.0,,,,,,,,,,,,,,
5208,PC080571,PCRP,0.8769618073426574,10.1084/jem.20112408,"['1540-9538', '0022-1007']",The Journal of Experimental Medicine,Rockefeller University Press,330.0,37.0,"['Immunology', 'Immunology and Allergy']",21.0,Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation,2012.0,2020.0,2020.0,2012.0,2012.0,22547653,48476333.0,2012.0,JOURNAL OF EXPERIMENTAL MEDICINE,Clinical Medicine,235.0,10.016,32.0,1.0,16.0,4.0,1.0,,1.0,,,,,,,,,,,1.0
6261,PC101165,PCRP,0.8974425352678572,10.1111/j.1365-2559.2011.04033.x,['0309-0167'],Histopathology,Wiley,283.0,161.0,,2.0,Prostate cancer and inflammation: the evidence,2011.0,2019.0,2020.0,2011.0,2011.0,22212087,47915038.0,2012.0,HISTOPATHOLOGY,Clinical Medicine,233.0,14.573,,,,,,,,,,,,,,,,,,
4965,PC074048,PCRP,0.9258429154639174,10.1038/nm.2100,"['1078-8956', '1546-170X']",Nature Medicine,Springer Science and Business Media LLC,242.0,50.0,,15.0,An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB,2010.0,2019.0,2020.0,2010.0,2010.0,20154697,44137733.0,2010.0,NATURE MEDICINE,Biomedical Research,232.0,6.79,9.0,1.0,,7.0,,,,,,,,,,,,,,
4157,PC060340,PCRP,0.912765533467742,10.1084/jem.20101956,"['1540-9538', '0022-1007']",The Journal of Experimental Medicine,Rockefeller University Press,294.0,73.0,"['Immunology', 'Immunology and Allergy']",19.0,Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells,2011.0,2020.0,2020.0,2011.0,2011.0,21930770,47265926.0,2011.0,JOURNAL OF EXPERIMENTAL MEDICINE,Clinical Medicine,230.0,8.33,10.0,1.0,3.0,6.0,,,,,,,,,,,,,,
6618,PC111703,PCRP,0.8371102280274657,10.1038/ncb3195,"['1465-7392', '1476-4679']",Nature Cell Biology,Springer Science and Business Media LLC,344.0,70.0,,21.0,MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation,2015.0,2019.0,2020.0,2015.0,2015.0,26147250,55142918.0,2015.0,NATURE CELL BIOLOGY,Biomedical Research,227.0,14.651,31.0,1.0,20.0,3.0,3.0,,1.0,,,,,1.0,,,,,,
6417,PC102171,PCRP,0.8083055407936508,10.1038/nm.2388,"['1078-8956', '1546-170X']",Nature Medicine,Springer Science and Business Media LLC,289.0,57.0,"['General Biochemistry, Genetics and Molecular Biology', 'General Medicine']",23.0,Lrp5 functions in bone to regulate bone mass,2011.0,2020.0,2020.0,2011.0,2011.0,21602802,46753196.0,2011.0,NATURE MEDICINE,Biomedical Research,225.0,7.231,12.0,2.0,3.0,,1.0,,1.0,,,,,,,,,,1.0,
6185,PC100950,PCRP,0.8490985501372984,10.1158/0008-5472.can-11-0532,"['0008-5472', '1538-7445']",Cancer Research,American Association for Cancer Research (AACR),223.0,,,12.0,Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors,2011.0,2016.0,2020.0,2011.0,2011.0,21868758,47377897.0,2011.0,CANCER RESEARCH,Clinical Medicine,225.0,7.345,9.0,,,9.0,,,,,,,,,,,,,,
4905,PC073887,PCRP,0.9530988099248804,10.1016/j.biomaterials.2010.11.028,['0142-9612'],Biomaterials,Elsevier BV,262.0,68.0,,6.0,Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy,2010.0,2019.0,2020.0,,2011.0,21167595,46216550.0,2011.0,BIOMATERIALS,Biomedical Research,223.0,8.436,,,,,,,,,,,,,,,,,,
5229,PC080665,PCRP,0.90282795,10.1073/pnas.0904720106,"['0027-8424', '1091-6490']",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,229.0,27.0,['Multidisciplinary'],14.0,Chimeric transcript discovery by paired-end transcriptome sequencing,2009.0,2017.0,2020.0,2009.0,2009.0,19592507,32693543.0,2009.0,PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,Biomedical Research,221.0,3.696,3.0,,,3.0,,,,,,,,,,,,,,
888,TS100078,TSCRP,0.9262410283707864,10.1073/pnas.1207846109,"['0027-8424', '1091-6490']",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,325.0,49.0,,6.0,Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution,2012.0,2017.0,2020.0,2012.0,2012.0,22927429,49236625.0,2012.0,PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,Biomedical Research,220.0,7.044,13.0,,11.0,,,1.0,,,,,,,,,,,1.0,
5059,PC080147,PCRP,0.9186493426917988,10.1200/jco.2010.31.5226,"['0732-183X', '1527-7755']",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),293.0,42.0,"['Cancer Research', 'Oncology']",4.0,Physical Activity and Survival After Prostate Cancer Diagnosis in the Health Professionals Follow-Up Study,2011.0,2019.0,2020.0,,2011.0,21205749,46258566.0,2011.0,JOURNAL OF CLINICAL ONCOLOGY,Clinical Medicine,219.0,7.149,63.0,,50.0,,1.0,1.0,5.0,,,,,,,1.0,,,1.0,2.0
6416,PC102171,PCRP,0.5939929908433734,10.1126/scitranslmed.3003161,"['1946-6234', '1946-6242']",Science Translational Medicine,American Association for the Advancement of Science (AAAS),390.0,48.0,['General Medicine'],27.0,Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study,2011.0,2020.0,2020.0,2011.0,2011.0,22133722,47690458.0,2011.0,SCIENCE TRANSLATIONAL MEDICINE,Biomedical Research,214.0,6.877000000000001,66.0,1.0,47.0,4.0,1.0,3.0,2.0,,,,,,,1.0,,,2.0,
3732,PC050782,PCRP,0.9170177818548388,10.1002/stem.29,"['1066-5099', '1549-4918']",Stem Cells,Wiley,214.0,38.0,,10.0,Functional Evidence that the Self-Renewal GeneNANOGRegulates Human Tumor Development,2009.0,2019.0,2020.0,,2009.0,19415763,31625453.0,2009.0,STEM CELLS,Biomedical Research,211.0,5.0089999999999995,6.0,,,6.0,,,,,,,,,,,,,,
720,TS060023,TSCRP,0.9496307768707484,10.1016/j.molcel.2010.05.017,['1097-2765'],Molecular Cell,Elsevier BV,239.0,32.0,,5.0,Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition,2010.0,2018.0,2020.0,,2010.0,20542007,44610645.0,2010.0,MOLECULAR CELL,Biomedical Research,210.0,5.37,2.0,1.0,,,,,,,,,,,,,,,,
3495,PC041225,PCRP,0.8010201230303908,10.1101/gad.511109,['0890-9369'],Genes & Development,Cold Spring Harbor Laboratory,221.0,,,12.0,Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS,2009.0,2017.0,2020.0,2009.0,2009.0,19451218,31725744.0,2009.0,GENES & DEVELOPMENT,Biomedical Research,208.0,5.164,3.0,,,2.0,,,,,,,,,,,,,1.0,
2589,PC030429,PCRP,0.6734598703174604,10.1186/1476-4598-3-29,['1476-4598'],Molecular Cancer,Springer Science and Business Media LLC,252.0,,,9.0,,2004.0,2016.0,2020.0,,2004.0,15482598,47606138.0,2004.0,MOLECULAR CANCER,Clinical Medicine,203.0,3.9810000000000003,2.0,,,2.0,,,,,,,,,,,,,,
5787,PC094266,PCRP,0.941556143909685,10.1038/nbt.1947,"['1087-0156', '1546-1696']",Nature Biotechnology,Springer Science and Business Media LLC,253.0,32.0,,14.0,An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells,2011.0,2019.0,2020.0,2011.0,2011.0,21841799,47180405.0,2011.0,NATURE BIOTECHNOLOGY,Biomedical Research,203.0,4.926,38.0,1.0,19.0,11.0,2.0,3.0,2.0,,,,,,,,,,,
4789,PC073643,PCRP,0.9707590878345358,10.1016/j.colsurfb.2010.03.039,['0927-7765'],Colloids and Surfaces B: Biointerfaces,Elsevier BV,259.0,59.0,,3.0,β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells,2010.0,2018.0,2020.0,,2010.0,20456930,44600845.0,2010.0,COLLOIDS AND SURFACES B-BIOINTERFACES,Chemistry,202.0,8.596,3.0,,,3.0,,,,,,,,,,,,,,
